Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia

por Davidson, Michael H.
Publicado 2015

Intensive statin therapy in India: Demonstrating efficacy and safety

por Davidson, Michael H.
Publicado 2016

Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia

por Benes, Lane B, Bassi, Nikhil S, Davidson, Michael H
Publicado 2016

Type 2 Diabetes and Cardiovascular Disease: Reducing the Risk

por Bartels, David W., Davidson, Michael H., Gong, William C.
Publicado 2007

Toxicological safety assessment of HempChoice® hemp oil extract; a proprietary extract consisting of a high concentration of cannabidiol (CBD) in addition to other phytocannabinoid...

por Dziwenka, Margitta, Coppock, Robert, Davidson, Michael H., Weder, Marc A.
Publicado 2023

Cardiorenal Safety of OTC Analgesics

por White, William B., Kloner, Robert A., Angiolillo, Dominick J., Davidson, Michael H.
Publicado 2018

CETP and SGLT2 inhibitor combination therapy improves glycemic control

por Khomtchouk, Bohdan B., Sun, Patrick, Ditmarsch, Marc, Kastelein, John J.P., Davidson, Michael H.
Publicado 2023

ω-6 Polyunsaturated Fatty Acids and Cardiometabolic Health: Current Evidence, Controversies, and Research Gaps

por Maki, Kevin C, Eren, Fulya, Cassens, Martha E, Dicklin, Mary R, Davidson, Michael H
Publicado 2018

Left ventricular mass regression, all-cause and cardiovascular mortality in chronic kidney disease: a meta-analysis

por Maki, Kevin C., Wilcox, Meredith L., Dicklin, Mary R., Kakkar, Rahul, Davidson, Michael H.
Publicado 2022

Indicators of the atherogenic lipoprotein phenotype measured with density gradient ultracentrifugation predict changes in carotid intima-media thickness in men and women

por Maki, Kevin C, Dicklin, Mary R, Davidson, Michael H, Mize, Patrick D, Kulkarni, Krishnaji R
Publicado 2012

Time-related trends in variability of cIMT changes in statin trials

por Davidson, Michael H., Tomassini, Joanne E., Jensen, Erin, Neff, David, Polis, Adam B., Tershakovec, Andrew M.
Publicado 2015

Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition

por Martin, Seth S, Ditmarsch, Marc, Simmons, Mark, Alp, Nicholas, Turner, Traci, Davidson, Michael H, Kastelein, John J P
Publicado 2022

Relationship of Abdominal Visceral and Subcutaneous Adipose Tissue With Lipoprotein Particle Number and Size in Type 2 Diabetes

por Sam, Susan, Haffner, Steven, Davidson, Michael H., D'Agostino, Ralph B., Feinstein, Steven, Kondos, George, Perez, Alfonso, Mazzone, Theodore
Publicado 2008

Relation of Abdominal Fat Depots to Systemic Markers of Inflammation in Type 2 Diabetes

por Sam, Susan, Haffner, Steven, Davidson, Michael H., D'Agostino, Ralph B., Feinstein, Steven, Kondos, George, Perez, Alfonso, Mazzone, Theodore
Publicado 2009

Hypertriglyceridemic Waist Phenotype Predicts Increased Visceral Fat in Subjects With Type 2 Diabetes

por Sam, Susan, Haffner, Steven, Davidson, Michael H., D'Agostino, Ralph B., Feinstein, Steven, Kondos, George, Perez, Alfonso, Mazzone, Theodore
Publicado 2009

Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©

por Jacobson, Terry A., Edelman, Steven V., Galipeau, Nina, Shields, Alan L., Mallya, Usha G., Koren, Andrew, Davidson, Michael H.
Publicado 2016

Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control

por Ray, Kausik K., Ginsberg, Henry N., Davidson, Michael H., Pordy, Robert, Bessac, Laurence, Minini, Pascal, Eckel, Robert H., Cannon, Christopher P.
Publicado 2016

Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels

por Nelson, Adam J., Sniderman, Allan D., Ditmarsch, Marc, Dicklin, Mary R., Nicholls, Stephen J., Davidson, Michael H., Kastelein, John J. P.
Publicado 2022

Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a random...

por Dunbar, Richard L., Nicholls, Stephen J., Maki, Kevin C., Roth, Eli M., Orloff, David G., Curcio, Danielle, Johnson, Judith, Kling, Douglas, Davidson, Michael H.
Publicado 2015

Lower On‐Treatment Low‐Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials

por Vallejo‐Vaz, Antonio J., Ginsberg, Henry N., Davidson, Michael H., Eckel, Robert H., Cannon, Christopher P., Lee, L. Veronica, Bessac, Laurence, Pordy, Robert, Letierce, Alexia, Ray, Kausik K.
Publicado 2018